Skip to main content
. 2022 Aug 16;14(8):1711. doi: 10.3390/pharmaceutics14081711

Table 2.

The results of in vitro assessed parameter of formulations of Run (1–17) for responses in optimization process of β–sito–Alg/Ch/NPs.

Runs Independent Variables Responses
X1, %w/v X2, %w/v X3, mM Y1, nm Y2 Y3, %
* 1 0.15 0.38 15.00 21.00 0.120 77.00
2 0.22 0.50 30.00 42.00 0.310 78.00
3 0.30 0.38 30.00 40.00 0.61 91.00
* 4 0.22 0.25 15.00 45.00 0.204 72.00
5 0.22 0.38 22.00 34.00 0.380 75.00
* 6 0.22 0.38 22.00 34.90 0.420 76.00
7 0.30 0.50 22.00 31.00 0.570 89.00
8 0.30 0.38 15.00 42.00 0.510 86.00
9 0.22 0.25 30.00 43.00 0.530 76.00
10 0.15 0.25 22.50 23.00 0.260 73.00
* 11 0.15 0.50 22.50 16.00 0.330 79.00
12 0.22 0.38 22.50 32.00 0.340 78.00
13 0.22 0.38 22.50 33.00 0.360 76.30
* 14 0.22 0.38 22.50 33.60 0.402 77.00
15 0.22 0.50 15.00 35.00 0.310 76.00
16 0.30 0.25 22.00 38.00 0.730 88.00
17 0.15 0.38 30.00 27.00 0.350 77.60

X1: Chitosan, %w/v, X2: Sodium alginate, %w/v, X3: Calcium chloride (mM), Y1: Particle size (nm), Y2: PDI, Y3: % Entrapment efficiency. * Replicas.